Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NGEN vs SLSN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SLSN Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 9–1 Matrix Metrics)

SLSN Overall Winner 6-Pillar Tally: NGEN 0 – 6 SLSN Matrix Metrics: NGEN 1 – 9 SLSN

As of Nov 16, 2026, Solesence, Inc. (SLSN) is the stronger overall head-to-head candidate over NGEN (NGEN) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NGEN carries a Unified Composite Score of 34.7/100 (SELL) at $1.82 (N/M Forward P/E, N/A operating margin), whereas SLSN carries 37.1/100 (SELL) at $1.60 (11.4x Forward P/E, 4.5% operating margin).

  • Defensive Composite Rating Caution: Although SLSN compares more favorably head-to-head, both NGEN (34.7/100 SELL) and SLSN (37.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NGEN vs SLSN
NGEN US Equity
NGEN
Institutional Equity
$1.82
-3.19% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.25β · 101% Vol
Unified Composite Score
34.7 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 64
RSI-14: 64.2 · SMA20: $1.46 · SMA50: $1.73
SLSN NASDAQ Head-to-Head Winner
Solesence, Inc. Common Stock
Perfumes, Cosmetics & Other Toilet Preparations
$1.60
+5.26% 1D
Market Cap $107.4M
TTM Revenue $61M
Forward P/E 11.4x
Beta / 30D Vol 1.44β · 238% Vol
Unified Composite Score
37.1 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 85
RSI-14: 85.3 · SMA20: $0.93 · SMA50: $0.88

6-Pillar Scorecard Institutional Category Breakdown (NGEN 0 – 6 SLSN)

Columns: Metric · NGEN · SLSN
1. Valuation Multiples SLSN
Forward P/E N/M 11.4x
Trailing P/E N/M 50.7x
PEG Ratio N/M N/M
EV / Revenue N/M 2.1x
2. Growth & Scale SLSN
Revenue Growth (YoY) N/A +38.1%
Earnings Growth (YoY) N/A -93.5%
TTM Revenue (USD) N/A $61M
Market Cap N/A $107.4M
3. Profitability & Quality SLSN
Gross Margin N/A 30.1%
Operating Margin N/A 4.5%
Net Profit Margin N/A 3.0%
Return on Equity (ROE) N/A 10.7%
4. Balance Sheet & Cash Flow SLSN
Cash Generation (TTM) N/A -$849,000
Cash Flow Margin N/A -1.4%
Net Cash / Leverage N/A ROE $22M Net Debt (1.73x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SLSN
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat SLSN
OpEx & R&D Intensity N/A 25.6% of Rev ($16M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Household & Personal Products Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NGEN (1) vs SLSN (9)
Institutional Metric NGEN SLSN Criterion Row Edge
Market Capitalization
Scale
N/A $107.4M Larger Scale SLSN
Trailing P/E Ratio
Valuation
N/M 50.7x Lower Multiple SLSN
Forward P/E Ratio
Valuation
N/M 11.4x Lower Multiple SLSN
Revenue Growth (YoY)
Growth
N/A +38.1% Higher Growth SLSN
Operating Margin (TTM)
Profitability
N/A 4.5% Higher Margin SLSN
Net Profit Margin
Profitability
N/A 3.0% Higher Margin SLSN
Return on Equity (ROE)
Capital Efficiency
N/A 10.7% Higher ROE SLSN
52-Week Range Position
Momentum
11% ($1–$6) 58% ($1–$2) Stronger Trend SLSN
Beta / 30D Volatility
Risk Regime
1.25β · 101% Vol 1.44β · 238% Vol Lower Realized Risk NGEN
Unified Institutional Score
Composite Signal
34.7 / 100 (SELL) 37.1 / 100 (SELL) Higher Composite SLSN
Trailing 12M Revenue (USD)
Operating Scale
N/A $61M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 30.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 2.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$849,000 ($22M Net Debt (1.73x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SLSN +63.31 pp
NGEN: +14.47% · SLSN: +77.78%
3M Horizon SLSN +74.16 pp
NGEN: +6.43% · SLSN: +80.59%
6M Horizon SLSN +78.0 pp
NGEN: -50.0% · SLSN: +28.0%
1Y Horizon SLSN +74.09 pp
NGEN: -69.51% · SLSN: +4.58%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NGEN vs SLSN. Trailing 12-month operating profitability (NGEN N/A vs SLSN 4.5%) and valuation multiples (NGEN N/M vs SLSN 11.4x Forward P/E) are benchmarked directly in Pillar 4 below.

NGEN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
SLSN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$61M
Gross Margin30.1%
Op. Margin4.5%
ROE / Fwd P/E10.7% · 11.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NGEN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NGEN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SLSN CONSOLIDATION
130d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact SLSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NGEN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SLSN Moat Profile Cyclical / Execution-Driven Positioning
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $107.4M market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment 25.6% of Rev ($16M)
90D Engineering Disclosures 0 Published

Investor FAQ NGEN vs SLSN Key Questions & Quantitative Answers

As of Nov 16, 2026, Solesence, Inc. (SLSN) is the stronger overall head-to-head candidate over NGEN (NGEN) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NGEN carries a Unified Composite Score of 34.7/100 (SELL) at $1.82 (N/M Forward P/E, N/A operating margin), whereas SLSN carries 37.1/100 (SELL) at $1.60 (11.4x Forward P/E, 4.5% operating margin). Defensive Composite Rating Caution: Although SLSN compares more favorably head-to-head, both NGEN (34.7/100 SELL) and SLSN (37.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

SLSN leads the Growth & Scale pillar: NGEN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SLSN at +38.1% YoY revenue growth and -93.5% YoY earnings growth on $61M TTM revenue (30.1% gross margin, 4.5% operating margin). On trailing 12-month operating scale, NGEN generates N/A in USD-normalized revenue versus $61M for SLSN. In operating R&D and SG&A reinvestment, NGEN deploys N/A (0 90-day corporate R&D disclosures) versus 25.6% of Rev ($16M) (0 disclosures) for SLSN.

SLSN screens cheaper on headline valuation multiples. NGEN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SLSN trades at 11.4x Forward P/E, 50.7x Trailing P/E, N/M PEG, and 2.1x EV/Revenue (-1.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NGEN (N/A ROE) versus SLSN (10.7% ROE) capital efficiency.

In options market volatility and institutional positioning, NGEN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.25β · 101% Vol realized risk). By comparison, SLSN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.44β · 238% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.